Latest Stock Market News

Its revenue from operations grew 37.8% YoY to Rs 3,952.5 crore in the quarter from Rs 2,867.4 crore in March 2022.

A total of 36,125 shares changed hands on the counter till 12:25PM (IST)

CLSA has initiated an outperform rating on Kotak Mahindra Bank and a buy rating on UltraTech Cement, while Jefferies has maintained its buy rating on Indian Hotels post Q4 results. CLSA downgraded Kotak Mahindra Bank to outperform post-March quarter results and UltraTech Cement to underperform with a target price of Rs 2150 and Rs 7900, respectively. Jefferies sees an incremental demand driver for FY24 and Motilal Oswal maintained its buy rating post-March quarter results.

RBL Bank, incorporated in the year 1943, is a banking company (having a market cap of Rs 9701.01 Crore).

Experts suggest that Sun Pharmaceuticals stock prices could exceed Rs 1,100 levels in the short term if current momentum continues, following a bounce back after retesting its 200-day moving average on the daily charts. Traders may consider accumulating the stock within the range of Rs 970-990. The pharma stock is trading above its 5, 10, 30, 50, and 200-day moving averages but below 20 and 100-day moving averages on the daily charts

Moreover, given the acquisition shall be funded through debt, and forgone other income, the brokerage expects the acquisition to be earnings dilutive and expect earnings to be impacted by -5%/-5% in FY24/FY25.

Hemang Jani, Equity Strategist & Senior Group VP at MOFSL,expects passenger vehicles and commercial vehicles to continue seeing growth, but there may be suppressed performance in the tractor industry. Kotak Bank has performed well with strong loan growth, NII, and asset quality. UltraTech is best positioned in the cement sector and expected to experience strong volume growth.

The Nifty Pharma index was trading 0.08 per cent down at 12604.1.

The Relative Strength Index of the stock stood at 60.79 on Tuesday.

The stock quoted a 52-week high price of Rs 419.55 and a 52-week low of Rs 206.1.